MIFs derived from these CD36+ CAFs activate myeloid‐derived suppressor cells (MDSCs) through the IL‐6/STAT‐3 pathway, promoting an immunosuppressive TME and enhancing tumor stem cell capabilities. This evidence concerns the gene IL6 and neoplasm.